Hyperimmune globulin to prevent congenital CMV infection [1]

New England Journal of Medicine

Volumn 370, Issue 26, 2014, Pages 2543-2545

  Hamprecht, Klaus ^a   Kagan, Karl Oliver ^a   Goelz, Rangmar ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY;

ANTIBODY RESPONSE; BINDING AFFINITY; CYTOMEGALOVIRUS INFECTION; DRUG HALF LIFE; HUMAN; INFECTION PREVENTION; LETTER; PREGNANT WOMAN; PRIORITY JOURNAL; VIRUS NEUTRALIZATION; VIRUS TRANSMISSION; CYTOMEGALOVIRUS; FEMALE; FETUS DISEASE; IMMUNOLOGY; NOTE; PREGNANCY; PREGNANCY COMPLICATION; VERTICAL TRANSMISSION; BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONGENITAL INFECTION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; NONHUMAN; OBSERVATIONAL STUDY; OPTIMAL DRUG DOSE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; VIRUS INFECTION;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FETAL DISEASES; HUMANS; IMMUNOGLOBULINS; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84903455500     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1405377     Document Type: Letter

References (5)

1. Revello MG, Lazzarotto T, Guerra B, et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med 2014;370:1316-26.
2. Nigro G, Adler SP, La Torre R, Best AM. Passive immunization during pregnancy for congenital cytomegalovirus infection. N Engl J Med 2005;353:1350-62. (Pubitemid 41362703)
3. Buxmann H, Stackelberg OM, Schlößer RL, et al. Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis. J Perinat Med 2012;40:439-46.
4. Thürmann PA, Sonnenburg-Chatzopoulos C, Lissner R. Pharmacokinetic characteristics and tolerability of a novel intravenous immunoglobulin preparation. Eur J Clin Pharmacol 1995;49:237-42.
5. Hamprecht K, Bissinger AL, Arellano-Galindo J, et al. Intrafamilial transmission of human cytomegalovirus (HCMV): long-term dynamics of epitope-specific antibody response in context of avidity maturation. J Clin Virol 2014;60:119-26.